Boesenbergia pandurata attenuates diet-induced obesity by activating AMP-activated protein kinase and regulating lipid metabolism

International Journal of Molecular Sciences

Volumn 13, Issue 1, 2012, Pages 994-1005

  Kim, Dae Young ^a   Kim, Myung Suk ^a   Sa, Bo Kyung ^a   Kim, Mi Bo ^a   Hwang, Jae Kwan ^a  

^a Yonsei University   (South Korea)

Author keywords

Amp activated protein kinase; Boesenbergia pandurata (roxb.) schltr.; Fatty liver; Lipid accumulation; Obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANTIOBESITY AGENT; BOESENBERGIA PANDURATA EXTRACT; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BOESENBERGIA PANDURATA; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; FAT MASS; FOOD INTAKE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; MEDICINAL PLANT; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RHIZOME; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE; 3T3 CELL LINE; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; EATING; HEPG2 CELL LINE; LIVER; METABOLISM; WEIGHT GAIN; ZINGIBERACEAE;

ANIMALIA; BOESENBERGIA PANDURATA; MUS;

3T3-L1 CELLS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-OBESITY AGENTS; CHOLESTEROL; DIET, HIGH-FAT; EATING; HEP G2 CELLS; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; PLANT EXTRACTS; RHIZOME; TRIGLYCERIDES; WEIGHT GAIN; ZINGIBERACEAE;

EID: 84863021980     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13010994     Document Type: Article

References (26)

1. Després, J.P.; Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 2006, 444, 881-887.
2. James, P.T.; Rigby, N.; Leach, R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur. J. Cardiovasc. Prev. Rehabil. 2004, 11, 3-8.
3. Fujioka, K. Management of obesity as a chronic disease: Nonpharmacologic, pharmacologic, and surgical options. Obes. Res. 2002, 10, S116-S123.
4. Semenkovich, C.F. Insulin resistance and atherosclerosis. J. Clin. Invest. 2006, 116, 1813-1822.
5. Shi, Y.; Burn, P. Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity. Nat. Rev. Drug. Discov. 2004, 3, 695-710.
6. Savage, D.B.; Petersen, K.F.; Shulman, GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 2007, 87, 507-520.
7. Olefsky, J.M. Fat talks, liver and muscle listen. Cell 2008, 134, 914-916.
8. Harvatine, K.J.; Bauman, D.E. SREBP1 and thyroid hormone responsive spot 14 (S14) are involved in the regulation of bovine mammary lipid synthesis during diet-induced milk fat depression and treatment with CLA. J. Nutr. 2006, 136, 2468-2474.
9. Boden, G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr. Diab. Rep. 2006, 6, 177-181.
10. Chen, N.; Bezzina, R.; Hinch, E. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr. Res. 2009, 29, 784-793.
11. Choi, H.; Eo, H.; Park, K. A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model. Biochem. Biophys. Res. Commun. 2007, 359, 419-425.
12. Hardie, D.G. AMPK: A key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond.) 2008, 32, S7-S12.
13. Ouadda, A.B.; Levy, E.; Ziv, E. Increased hepatic lipogenesis in insulin resistance and type 2 diabetes is associated with AMPK signalling pathway up-regulation in Psammomys obesus. Biosci. Rep. 2009, 29, 283-292.
14. Osler, M.E.; Zierath, J.R. Adenosine 5'-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology 2008, 149, 935-941.
15. Hasani-Ranjbar, S.; Nayebi, N.; Larijani, B.; Abdollahi, M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J. Gastroenterol. 2009, 15, 3073-3085.
16. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127, 1109-1122.
17. Lee, M.S.; Kim, C.T.; Kim, Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann. Nutr. Metab. 2009, 54, 151-157.
18. Kim, W.S.; Lee, Y.S.; Cha, S.H. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E812-E819.
19. Yun, J.M.; Kwon, H.; Hwang, J.K. In vitro anti-inflammatory activity of panduratin A isolated from Kaempferia pandurata in RAW264.7 cells. Planta Med. 2003, 69, 1102-1108.
20. Shindo, K.; Kato, M.; Kinoshita, A.; Kobayashi, A.; Koike, Y. Analysis of antioxidant activities contained in the Boesenbergia pandurata Schult. Rhizome. Biosci. Biotechnol. Biochem. 2006, 70, 2281-2284.
21. Lee, Y.S.; Kim, W.S.; Kim, K.H. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55, 2256-2264.
22. Kim, D.Y.; Lee, M.S.; Jo, K.; Lee, K.-E. Therapeutic potential of panduratin A, LKB1-dependent AMP-activated protein kinase stimulator, with activation of PPARα/δ for the treatment of obesity. Diabetes. Obes. Metab. 2011, 13, 584-593.
23. Wellen, K.E.; Hotamisligil, G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112, 1785-1788.
24. Amini, Z.; Boyd, B.; Doucet, J.; Ribnicky, D.M.; Stephens, J.M. St. John's Wort inhibits adipocyte differentiation and induces insulin resistance in adipocytes. Biochem. Biophys. Res. Commun. 2009, 338, 146-149.
25. Han, C.; Wang, J.; Li, L.; Zhang, Z.; Wang, L.; Pan, Z. The role of insulin and glucose in goose primary hepatocyte triglyceride accumulation. J. Exp. Biol. 2009, 212, 1553-1558.
26. Tuchinda, P.; Reutrakul, V.; Claeson, P. Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata. Phytochemistry 2002, 59, 169-173.